Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...

Scientists have linked roughly five percent of adult cancers to mutations in genes called FOCAD and TTC37. Another gene known ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

The American Cancer Society recently predicted there will be around 155,000 new cases of colorectal cancer and 52,900 deaths ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...